Application 219859
- Type
- ANDA
- Sponsor
- GRAVITI PHARMS
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | LOSARTAN POTASSIUM | LOSARTAN POTASSIUM | TABLET;ORAL | 25MG | No | No |
| 002 | LOSARTAN POTASSIUM | LOSARTAN POTASSIUM | TABLET;ORAL | 50MG | No | No |
| 003 | LOSARTAN POTASSIUM | LOSARTAN POTASSIUM | TABLET;ORAL | 100MG | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A219859-001 | LOSARTAN POTASSIUM | LOSARTAN POTASSIUM | 25MG | TABLET / ORAL | AB | 2025-09-19 | |
| A219859-002 | LOSARTAN POTASSIUM | LOSARTAN POTASSIUM | 50MG | TABLET / ORAL | AB | 2025-09-19 | |
| A219859-003 | LOSARTAN POTASSIUM | LOSARTAN POTASSIUM | 100MG | TABLET / ORAL | AB | 2025-09-19 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A219859-001 | AB |
| A219859-002 | AB |
| A219859-003 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A219859-001 | LOSARTAN POTASSIUM | 25MG | TABLET / ORAL | AB | 2025-09-19 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | A219859-002 | LOSARTAN POTASSIUM | 50MG | TABLET / ORAL | AB | 2025-09-19 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | A219859-003 | LOSARTAN POTASSIUM | 100MG | TABLET / ORAL | AB | 2025-09-19 | 84e616aacf4f… | |
| 2026-08-18 06:07:40 | 2026-07 | A219859-001 | LOSARTAN POTASSIUM | 25MG | TABLET / ORAL | AB | 2025-09-19 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | A219859-002 | LOSARTAN POTASSIUM | 50MG | TABLET / ORAL | AB | 2025-09-19 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | A219859-003 | LOSARTAN POTASSIUM | 100MG | TABLET / ORAL | AB | 2025-09-19 | caaa826d4ba7… | |
| 2026-02-19 14:30 UTC | 2026-02 | A219859-001 | LOSARTAN POTASSIUM | 25MG | TABLET / ORAL | AB | 2025-09-19 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A219859-002 | LOSARTAN POTASSIUM | 50MG | TABLET / ORAL | AB | 2025-09-19 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A219859-003 | LOSARTAN POTASSIUM | 100MG | TABLET / ORAL | AB | 2025-09-19 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A219859-001 | LOSARTAN POTASSIUM | 25MG | TABLET / ORAL | AB | 2025-09-19 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A219859-002 | LOSARTAN POTASSIUM | 50MG | TABLET / ORAL | AB | 2025-09-19 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A219859-003 | LOSARTAN POTASSIUM | 100MG | TABLET / ORAL | AB | 2025-09-19 | 31067a03dcf5… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A219859-001 | LOSARTAN POTASSIUM | 25MG | TABLET / ORAL | AB | 2025-09-19 | a50c72e98297… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A219859-002 | LOSARTAN POTASSIUM | 50MG | TABLET / ORAL | AB | 2025-09-19 | a50c72e98297… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A219859-003 | LOSARTAN POTASSIUM | 100MG | TABLET / ORAL | AB | 2025-09-19 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A219859-001 | AB | 1 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | A219859-002 | AB | 1 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | A219859-003 | AB | 1 | 84e616aacf4f… |
| 2026-08-18 06:07:40 | 2026-07 | A219859-001 | AB | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | A219859-002 | AB | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | A219859-003 | AB | 1 | caaa826d4ba7… |
| 2026-02-19 14:30 UTC | 2026-02 | A219859-001 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A219859-002 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A219859-003 | AB | 1 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A219859-001 | AB | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A219859-002 | AB | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A219859-003 | AB | 1 | 31067a03dcf5… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A219859-001 | AB | 1 | a50c72e98297… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A219859-002 | AB | 1 | a50c72e98297… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A219859-003 | AB | 1 | a50c72e98297… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Losartan potassium Tablets, 25 mg | LOSARTAN POTASSIUM | Jubilant Cadista Pharmaceuticals Inc. | 1bf520a2-a50e-a6ae-0fdf-9be4e69729c0 | 2024-12-12 | Boxed warning, Warnings, Adverse reactions | LOSARTAN POTASSIUM |
| Losartan Potassium | LOSARTAN POTASSIUM | Bryant Ranch Prepack | 43fa4762-cc0c-4a3b-a527-6aa7fb7c5464 | 2024-08-27 | Boxed warning, Warnings, Adverse reactions | Losartan Potassium LOSARTAN POTASSIUM |
| Losartan Potassium | LOSARTAN POTASSIUM | A-S Medication Solutions | f68fd1a2-1cbf-47c8-b8c4-df49cf17540e | 2024-08-26 | Boxed warning, Warnings, Adverse reactions | Losartan Potassium LOSARTAN POTASSIUM |
| Losartan Potassium | LOSARTAN POTASSIUM | Bryant Ranch Prepack | de987691-f659-45ab-9c53-402ef7421f4b | 2024-08-26 | Boxed warning, Warnings, Adverse reactions | Losartan Potassium LOSARTAN POTASSIUM |
| Losartan Potassium | LOSARTAN POTASSIUM | Proficient Rx LP | 4b298291-4251-4af8-a436-58a3443a7978 | 2024-08-01 | Boxed warning, Warnings, Adverse reactions | Losartan Potassium LOSARTAN POTASSIUM |
| LOSARTAN POTASSIUM 100 mg | LOSARTAN POTASSIUM | NuCare Pharmaceuticals,Inc. | a955160f-3c2d-3366-e053-2a95a90a65ea | 2024-07-17 | Boxed warning, Warnings, Adverse reactions | LOSARTAN POTASSIUM |
| Losartan Potassium | LOSARTAN POTASSIUM | NuCare Pharmaceuticals,Inc. | aa58c629-f7d9-a6e0-e053-2995a90ac188 | 2024-07-17 | Boxed warning, Warnings, Adverse reactions | Losartan Potassium LOSARTAN POTASSIUM |
| Losartan Potassium | LOSARTAN POTASSIUM | NuCare Pharmaceuticals,iNc. | 54b363c4-00bb-08db-e054-00144ff8d46c | 2024-07-17 | Boxed warning, Warnings, Adverse reactions | Losartan Potassium LOSARTAN POTASSIUM |
| Losartan Potassium | LOSARTAN POTASSIUM | NuCare Pharmaceuticals,Inc. | 9c0809dc-cbdd-1a33-e053-2995a90a4825 | 2024-06-20 | Boxed warning, Warnings, Adverse reactions | Losartan Potassium LOSARTAN POTASSIUM |
| Losartan Potassium | LOSARTAN POTASSIUM | NuCare Pharmaceuticals,Inc. | 9f1c20aa-2028-412d-e053-2995a90a1368 | 2024-06-20 | Boxed warning, Warnings, Adverse reactions | Losartan Potassium LOSARTAN POTASSIUM |
| Losartan Potassium | LOSARTAN POTASSIUM | NuCare Pharmaceuticals,Inc. | a11075f1-f7d0-0c3d-e053-2995a90a0c9d | 2024-06-20 | Boxed warning, Warnings, Adverse reactions | Losartan Potassium LOSARTAN POTASSIUM |
| Losartan Potassium | LOSARTAN POTASSIUM | NuCare Pharmaceuticals,Inc. | a1123700-f4c7-2b62-e053-2a95a90a87d6 | 2024-06-20 | Boxed warning, Warnings, Adverse reactions | Losartan Potassium LOSARTAN POTASSIUM |
| Losartan Potassium | LOSARTAN POTASSIUM | NuCare Pharmaceuticals,Inc. | 9130921b-02f0-82d6-e053-2995a90a9c0a | 2024-06-19 | Boxed warning, Warnings, Adverse reactions | Losartan Potassium LOSARTAN POTASSIUM |
| Losartan Potassium | LOSARTAN POTASSIUM | NuCare Pharmaceuticals,Inc. | 91305ca4-7d56-2052-e053-2995a90a5d61 | 2024-06-19 | Boxed warning, Warnings, Adverse reactions | Losartan Potassium LOSARTAN POTASSIUM |
| Losartan Potassium | LOSARTAN POTASSIUM | NuCare Pharmaceuticals,Inc. | 97a50b38-f5b3-0a96-e053-2995a90a345f | 2024-06-19 | Boxed warning, Warnings, Adverse reactions | Losartan Potassium LOSARTAN POTASSIUM |
| Losartan Potassium | LOSARTAN POTASSIUM | NuCare Pharmaceuticals,Inc. | 8c2b3412-254b-8fa9-e053-2a95a90a7dc6 | 2024-06-18 | Boxed warning, Warnings, Adverse reactions | Losartan Potassium LOSARTAN POTASSIUM |
| Losartan Potassium | LOSARTAN POTASSIUM | NuCare Pharmaceuticals,Inc. | 6eec2a4c-6b5c-11a5-e053-2991aa0aa56b | 2024-06-10 | Boxed warning, Warnings, Adverse reactions | Losartan Potassium LOSARTAN POTASSIUM |
| Losartan Potassium | LOSARTAN POTASSIUM | A-S Medication Solutions | cff0c9eb-fafd-48e7-a053-036b676bf57d | 2023-10-24 | Boxed warning, Warnings, Adverse reactions | Losartan Potassium LOSARTAN POTASSIUM |
| Losartan Potassium | LOSARTAN POTASSIUM | A-S Medication Solutions | 679be0b9-bb60-4970-ad50-0041a6d67bf8 | 2023-03-15 | Boxed warning, Warnings, Adverse reactions | Losartan Potassium LOSARTAN POTASSIUM |
| Losartan Potassium | LOSARTAN POTASSIUM | A-S Medication Solutions | 0e0a06f3-b8bd-4178-a519-ed80362e33c2 | 2023-03-12 | Boxed warning, Warnings, Adverse reactions | Losartan Potassium LOSARTAN POTASSIUM |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.